Triple Combination of Pevonedistat and Venetoclax Plus Azacitidine in Adults With Acute Myeloid Leukemia Who Are Unfit for Intensive Chemotherapy
Condition: Acute Myeloid Leukemia Interventions: Drug: Pevonedistat; Drug: Venetoclax; Drug: Azacitidine Sponsor: Takeda Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials